Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells.

MLA

Ko M.E., et al. Deep Profiling of Apoptotic Pathways with Mass Cytometry Identifies a Synergistic Drug Combination for Killing Myeloma Cells. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305108543&authtype=sso&custid=ns315887.

APA

Ko M.E., Fedele P.L., Teh C.E., Gong J.-N., Grigoriadis G., Segal D., Tan T., Vandenberg C.J., Low M.S.Y., Harrison S.J., Strasser A., Roberts A.W., Huang D.C.S., Nolan G.P., & Gray D.H.D. (2020). Deep profiling of apoptotic pathways with mass cytometry identifies a synergistic drug combination for killing myeloma cells.

Chicago

Ko M.E., Fedele P.L., Teh C.E., Gong J.-N., Grigoriadis G., Segal D., Tan T., et al. 2020. “Deep Profiling of Apoptotic Pathways with Mass Cytometry Identifies a Synergistic Drug Combination for Killing Myeloma Cells.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1305108543&authtype=sso&custid=ns315887.